Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Theresa Akoto"'
Autor:
Divya Bhagirath, Michael Liston, Theresa Akoto, Byron Lui, Barbara A. Bensing, Ashok Sharma, Sharanjot Saini
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-16 (2021)
Abstract Neuroendocrine prostate cancer (NEPC), a highly aggressive variant of castration-resistant prostate cancer (CRPC), often emerges upon treatment with androgen pathway inhibitors, via neuroendocrine differentiation. Currently, NEPC diagnosis i
Externí odkaz:
https://doaj.org/article/d5214699fc2a4b7883f1e1dd59762ab6
Autor:
Theresa Akoto, Jingwen Cai, Sarah Nicholas, Hayden McCord, Amy J. Estes, Hongyan Xu, Dimitrios Karamichos, Yutao Liu
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 8; Pages: 7437
Biomechanical and molecular stresses may contribute to the pathogenesis of keratoconus (KC). We aimed to profile the transcriptomic changes in healthy primary human corneal (HCF) and KC-derived cells (HKC) combined with TGFβ1 treatment and cyclic me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::611edeed99064013da16396b17614901
Publikováno v:
International journal of molecular sciences. 23(18)
Keratoconus (KC) is one of the most significant corneal disorders worldwide, characterized by the progressive thinning and cone-shaped protrusion of the cornea, which can lead to severe visual impairment. The prevalence of KC varies greatly by ethnic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d704557b499cb832479f9e21b5bcbf9
https://pubmed.ncbi.nlm.nih.gov/36142709
https://pubmed.ncbi.nlm.nih.gov/36142709
Autor:
Byron Lui, Sharanjot Saini, Divya Bhagirath, Shahana Majid, Michael Liston, Z. Laura Tabatabai, Nikhil Patel, Rajvir Dahiya, Theresa Akoto, Dat My To, Thao Ly Yang
Publikováno v:
Oncogene, vol 39, iss 49
Oncogene
Oncogene
Therapy-induced neuroendocrine prostate cancer (NEPC), an extremely aggressive variant of castration-resistant prostate cancer (CRPC), is increasing in incidence with the widespread use of highly potent androgen receptor (AR)-pathway inhibitors (APIs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb17214138881bf2cefc82ef0a9811eb
https://escholarship.org/uc/item/4p42x5q3
https://escholarship.org/uc/item/4p42x5q3
Publikováno v:
Oncotarget
Prostate cancer (PCa) is a significant cause of male morbidity in the United States. Despite recent advances in diagnosis and therapeutic interventions, significant fraction of cases still progress to an advanced stage. Various genetic/epigenetic ele
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42c43474e58d71f51a6d73cc935ade2a
https://pubmed.ncbi.nlm.nih.gov/33473254
https://pubmed.ncbi.nlm.nih.gov/33473254
Publikováno v:
Cancer drug resistance (Alhambra, Calif.)
Prostate cancer is a condition commonly associated with men worldwide. Androgen deprivation therapy remains one of the targeted therapies. However, after some years, there is biochemical recurrence and metastatic progression into castration-resistant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::614f4b29557ee8358e5fd4f1e3818133
https://doi.org/10.20517/cdr.2020.30
https://doi.org/10.20517/cdr.2020.30